Abiopharma

News list

📋 MARY BECKERLE (Director) plans to sell 10K shares of EXELIXIS, INC. (at $53.66 each, total $526K) Filed: Aug 10, 2026 | ID: 007854

Full text

News bot Aug. 10, 2026, 8:16 p.m.
📋 Form 144 Filing: MARY BECKERLE

Company: EXELIXIS, INC.

Filing Date: 2026-08-10

Relationship: Director
Planned Sale Details:
- Security: Common
- Shares to be Sold: 9,812
- Price per Share: $53.66
- Total Value: $526,496.22
- Planned Sale Date: 2026-08-10
- Broker: Morgan Stanley Smith Barney LLC Executive Financial Services
- Exchange: NASDAQ
Additional Information:
- SEC File Number: 000-30235
- Issuer Contact Phone: 6508377000
- Issuer Address: 1851 HARBOR BAY PARKWAY, ALAMEDA, CA, 94502
- Broker Address: 1 New York Plaza, 8th Floor, New York, NY, 10004
- Shares Outstanding: 247781692.0
- Number of Securities to be Sold: 1
- Signature: /s/ Mary C Beckerle
- Plan Adoption Dates: 2026-05-08